MNC加码体内CAR-T布局 全球并购超50亿美元

DoNews
Dec 05, 2025

近年来,MNC频繁布局体内CAR-T领域,累计完成超50亿美元并购交易。艾伯维于2024年1月与Umoja达成合作,并在2025年6月以21亿美元投资Capstan,其核心管线CPTX2309采用靶向脂质纳米颗粒(tLNPs)递送RNA,处于I期临床,用于治疗B细胞介导的自身免疫性疾病。安斯泰来于2024年2月与Kelonia合作开发自体生成CAR-T,潜在交易总额超8.75亿美元;诺华于2024...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10